Abstract
Purification of progenitor toxin of Clostridium botulinum type B strain Okra was undertaken by sequential steps of acid precipitation, extraction, ammonium sulfate precipitation, ribonuclease digestion, acid precipitation, protamine treatment, sulphopropyl-Sephadex chromatography, and Sephadex G-200 gel filtration. Two different molecular-sized toxins, named large (L) and medium (M) toxins, were obtained. L toxin was centrifugally homogeneous but electrophoretically heterogeneous. It contained 2.5 × 108 to 3.0 × 108 mean lethal doses per mg of nitrogen, and its sedimentation constant was 16S. M toxin was centrifugally and electrophoretically homogeneous. It contained 5.5 × 108 to 6.0 × 108 mean lethal doses per mg of nitrogen, and its sedimentation constant was 12S. The presence of both L and M toxins in spent culture was demonstrated. It seems justified, therefore, to call both progenitor toxins. Both consisted of toxic and nontoxic components. The toxic components of L and M toxins appeared to be identical with each other. The nontoxic component of L toxin was 12S and possessed a hemagglutinin activity of about 0.5% that of type A crystalline toxin; that of M toxin was 7S and possessed no hemagglutinin activity. They were antigenically related but not identical.
Full text
PDF![750](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/232c/423017/f9ea0e4a2832/iai00250-0070.png)
![751](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/232c/423017/1acd214ce9ce/iai00250-0071.png)
![752](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/232c/423017/68e322c92c09/iai00250-0072.png)
![753](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/232c/423017/8e07ee7097f2/iai00250-0073.png)
![754](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/232c/423017/3fde58a0fac1/iai00250-0074.png)
![755](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/232c/423017/57368d5d689f/iai00250-0075.png)
![756](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/232c/423017/9bbd03ec356d/iai00250-0076.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BUTLER W. T. HEMAGGLUTINATION STUDIES WITH FORMALINIZED ERYTHROCYTES. EFFECT OF BIS-DIAZO-BENZIDINE AND TANNIC ACID TREATMENT ON SENSITIZATION BY SOLUBLE ANTIGEN. J Immunol. 1963 May;90:663–671. [PubMed] [Google Scholar]
- Beers W. H., Reich E. Isolation and characterization of Clostridium botulinum type B toxin. J Biol Chem. 1969 Aug 25;244(16):4473–4479. [PubMed] [Google Scholar]
- Boroff D. A., Fleck U. Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum. J Bacteriol. 1966 Nov;92(5):1580–1581. doi: 10.1128/jb.92.5.1580-1581.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DUFF J. T., KLERER J., BIBLER R. H., MOORE D. E., GOTTFRIED C., WRIGHT G. G. Studies on immunity to toxins of Clostridium botulinum. II. Production and purification of type B toxin for toxoid. J Bacteriol. 1957 May;73(5):597–601. doi: 10.1128/jb.73.5.597-601.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DasGupta B. R., Boroff D. A., Cheong K. Isolation of chromatographically pure toxin of Clostridium botulinum type B. Biochem Biophys Res Commun. 1968 Sep 30;32(6):1057–1063. doi: 10.1016/0006-291x(68)90137-x. [DOI] [PubMed] [Google Scholar]
- DasGupta B. R., Boroff D. A. Separation of toxin and hemagglutinin from crystalline toxin of Clostridium botulinum type A by anion exchange chromatography and determination of their dimensions by gel filtration. J Biol Chem. 1968 Mar 10;243(5):1065–1072. [PubMed] [Google Scholar]
- Gerwing J., Dolman C. E., Kason D. V., Tremaine J. H. Purification and characterization of Clostridium botulinum type B oxin. J Bacteriol. 1966 Feb;91(2):484–487. doi: 10.1128/jb.91.2.484-487.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kitamura M., Sakaguchi S., Sakaguchi G. Purification and some properties of Clostridium botulinum type-E toxin. Biochim Biophys Acta. 1968 Oct 21;168(2):207–217. doi: 10.1016/0005-2795(68)90144-x. [DOI] [PubMed] [Google Scholar]
- Kitamura M., Sakaguchi S., Sakaguchi G. Significance of 12S toxin of Clostridium botulinum type E. J Bacteriol. 1969 Jun;98(3):1173–1178. doi: 10.1128/jb.98.3.1173-1178.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LAMANNA C., LOWENTHAL J. P. The lack of identity between hemagglutinin and the toxin of type A botulinal organism. J Bacteriol. 1951 Jun;61(6):751–752. doi: 10.1128/jb.61.6.751-752.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Lamanna C., Glassman H. N. The Isolation of Type B Botulinum Toxin. J Bacteriol. 1947 Nov;54(5):575–584. doi: 10.1128/jb.54.5.575-584.1947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lamanna C., Sakaguchi G. Botulinal toxins and the problem of nomenclature of simple toxins. Bacteriol Rev. 1971 Sep;35(3):242–249. doi: 10.1128/br.35.3.242-249.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- REISFELD R. A., LEWIS U. J., WILLIAMS D. E. Disk electrophoresis of basic proteins and peptides on polyacrylamide gels. Nature. 1962 Jul 21;195:281–283. doi: 10.1038/195281a0. [DOI] [PubMed] [Google Scholar]
- Sakaguchi G., Sakaguchi S., Kondo H. Rapid bioassay for Clostridium botulinum type-E toxins by intravenous injection into mice. Jpn J Med Sci Biol. 1968 Dec;21(6):369–378. doi: 10.7883/yoken1952.21.369. [DOI] [PubMed] [Google Scholar]
- Sakaguchi G., Sakaguchi S., Kozaki S., Sugii S., Oishi I. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography. Jpn J Med Sci Biol. 1974 Jun;27(3):161–172. doi: 10.7883/yoken1952.27.161. [DOI] [PubMed] [Google Scholar]
- WAGMAN J., BATEMAN J. B. The behavior of the bolulinus toxins in the ultracentrifuge. Arch Biochem Biophys. 1951 May;31(3):424–430. doi: 10.1016/0003-9861(51)90158-0. [DOI] [PubMed] [Google Scholar]